Report cover image

Global Necrotizing Ulcerative Gingivitis (NUG) Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 199 Pages
SKU # APRC20361597

Description

Summary

According to APO Research, The global Necrotizing Ulcerative Gingivitis (NUG) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Necrotizing Ulcerative Gingivitis (NUG) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Necrotizing Ulcerative Gingivitis (NUG) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Necrotizing Ulcerative Gingivitis (NUG) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Necrotizing Ulcerative Gingivitis (NUG) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Necrotizing Ulcerative Gingivitis (NUG) include Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics, Otsuka Pharmaceutical, GlaxoSmithKline, Mylan, Merck, Novartis and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Necrotizing Ulcerative Gingivitis (NUG), market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Necrotizing Ulcerative Gingivitis (NUG), also provides the revenue of main regions and countries. Of the upcoming market potential for Necrotizing Ulcerative Gingivitis (NUG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Necrotizing Ulcerative Gingivitis (NUG) revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Necrotizing Ulcerative Gingivitis (NUG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Necrotizing Ulcerative Gingivitis (NUG) revenue, projected growth trends, production technology, application and end-user industry.

Necrotizing Ulcerative Gingivitis (NUG) Segment by Company

Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Otsuka Pharmaceutical
GlaxoSmithKline
Mylan
Merck
Novartis
Sanofi
Teva Pharmaceutical
Necrotizing Ulcerative Gingivitis (NUG) Segment by Type

Medication
Surgery
Necrotizing Ulcerative Gingivitis (NUG) Segment by Application

Homecare
Pharmacies
Hospitals
Others
Necrotizing Ulcerative Gingivitis (NUG) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Necrotizing Ulcerative Gingivitis (NUG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Necrotizing Ulcerative Gingivitis (NUG) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Necrotizing Ulcerative Gingivitis (NUG).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Necrotizing Ulcerative Gingivitis (NUG) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Necrotizing Ulcerative Gingivitis (NUG) revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Necrotizing Ulcerative Gingivitis (NUG) Market by Type
1.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Surgery
1.3 Necrotizing Ulcerative Gingivitis (NUG) Market by Application
1.3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Homecare
1.3.3 Pharmacies
1.3.4 Hospitals
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Necrotizing Ulcerative Gingivitis (NUG) Market Dynamics
2.1 Necrotizing Ulcerative Gingivitis (NUG) Industry Trends
2.2 Necrotizing Ulcerative Gingivitis (NUG) Industry Drivers
2.3 Necrotizing Ulcerative Gingivitis (NUG) Industry Opportunities and Challenges
2.4 Necrotizing Ulcerative Gingivitis (NUG) Industry Restraints
3 Global Growth Perspective
3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Perspective (2020-2031)
3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Growth Trends by Region
3.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2020-2025)
3.2.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Players
4.1.1 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Players (2020-2025)
4.1.2 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Players (2020-2025)
4.1.3 Global Necrotizing Ulcerative Gingivitis (NUG) Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Necrotizing Ulcerative Gingivitis (NUG) Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Necrotizing Ulcerative Gingivitis (NUG) Key Players Headquarters & Area Served
4.4 Global Necrotizing Ulcerative Gingivitis (NUG) Players, Product Type & Application
4.5 Global Necrotizing Ulcerative Gingivitis (NUG) Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market CR5 and HHI
4.6.3 2024 Necrotizing Ulcerative Gingivitis (NUG) Tier 1, Tier 2, and Tier 3
5 Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
5.1 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
5.3 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Type (2020-2031)
6 Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
6.1 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
6.3 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Comapny Information
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.1.4 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.1.5 Abbott Laboratories Recent Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Comapny Information
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.2.4 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.2.5 Eli Lilly and Company Recent Developments
7.3 Hindustan Antibiotics
7.3.1 Hindustan Antibiotics Comapny Information
7.3.2 Hindustan Antibiotics Business Overview
7.3.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.3.4 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.3.5 Hindustan Antibiotics Recent Developments
7.4 Otsuka Pharmaceutical
7.4.1 Otsuka Pharmaceutical Comapny Information
7.4.2 Otsuka Pharmaceutical Business Overview
7.4.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.4.4 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.4.5 Otsuka Pharmaceutical Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Comapny Information
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.5.4 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.5.5 GlaxoSmithKline Recent Developments
7.6 Mylan
7.6.1 Mylan Comapny Information
7.6.2 Mylan Business Overview
7.6.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.6.4 Mylan Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.6.5 Mylan Recent Developments
7.7 Merck
7.7.1 Merck Comapny Information
7.7.2 Merck Business Overview
7.7.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.7.4 Merck Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.7.5 Merck Recent Developments
7.8 Novartis
7.8.1 Novartis Comapny Information
7.8.2 Novartis Business Overview
7.8.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.8.4 Novartis Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.8.5 Novartis Recent Developments
7.9 Sanofi
7.9.1 Sanofi Comapny Information
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.9.4 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.9.5 Sanofi Recent Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Comapny Information
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (2020-2025)
7.10.4 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
7.10.5 Teva Pharmaceutical Recent Developments
8 North America
8.1 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue (2020-2031)
8.2 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
8.2.1 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2025)
8.2.2 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2026-2031)
8.3 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Type (2020-2031)
8.4 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
8.4.1 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2025)
8.4.2 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2026-2031)
8.5 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Application (2020-2031)
8.6 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country
8.6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020-2025)
8.6.3 North America Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue (2020-2031)
9.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
9.2.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2025)
9.2.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2026-2031)
9.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Type (2020-2031)
9.4 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
9.4.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2025)
9.4.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2026-2031)
9.5 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Application (2020-2031)
9.6 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country
9.6.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020-2025)
9.6.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Necrotizing Ulcerative Gingivitis (NUG) Revenue (2020-2031)
10.2 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
10.2.1 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2025)
10.2.2 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2026-2031)
10.3 China Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Type (2020-2031)
10.4 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
10.4.1 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2025)
10.4.2 China Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2026-2031)
10.5 China Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue (2020-2031)
11.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
11.2.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2025)
11.2.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2026-2031)
11.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Type (2020-2031)
11.4 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
11.4.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2025)
11.4.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2026-2031)
11.5 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Application (2020-2031)
11.6 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country
11.6.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020-2025)
11.6.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue (2020-2031)
12.2 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2031)
12.2.1 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2020-2025)
12.2.2 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Type (2026-2031)
12.3 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Type (2020-2031)
12.4 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2031)
12.4.1 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2020-2025)
12.4.2 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Application (2026-2031)
12.5 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue Share by Application (2020-2031)
12.6 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country
12.6.1 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2020-2025)
12.6.3 SAMEA Necrotizing Ulcerative Gingivitis (NUG) Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.